Cargando…

Association of combination statin and antihypertensive therapy with reduced Alzheimer’s disease and related dementia risk

BACKGROUND: Hyperlipidemia and hypertension are modifiable risk factors for Alzheimer’s disease and related dementias (ADRD). Approximately 25% of adults over age 65 use both antihypertensives (AHTs) and statins for these conditions. While a growing body of evidence found statins and AHTs are indepe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barthold, Douglas, Joyce, Geoffrey, Diaz Brinton, Roberta, Wharton, Whitney, Kehoe, Patrick Gavin, Zissimopoulos, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055882/ https://www.ncbi.nlm.nih.gov/pubmed/32130251 http://dx.doi.org/10.1371/journal.pone.0229541

Ejemplares similares

The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity
por: Barthold, Douglas, et al.
Publicado: (2018)

Statin therapy and risk of Alzheimer's and age‐related neurodegenerative diseases
por: Torrandell‐Haro, Georgina, et al.
Publicado: (2020)

Do Patient Concerns About Antihypertensive Use For Dementia Prevention Vary By Current Use Of Antihypertensive?
por: Lee, Woojung, et al.
Publicado: (2019)

Benzodiazepine use and the risk of dementia
por: Joyce, Geoffrey, et al.
Publicado: (2022)

Diagnosis of Behavioral Symptoms of Dementia and CNS-Active Drug Use Among Diverse Persons Living With Dementia
por: Thunell, Johanna, et al.
Publicado: (2021)

Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020)

THE IMPACT OF MANDATED COGNITIVE ASSESSMENTS ON ALZHEIMER’S DISEASE AND RELATED DEMENTIA DIAGNOSIS RATES
por: Thunell, Johanna, et al.
Publicado: (2019)

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease
por: Geifman, Nophar, et al.
Publicado: (2017)

Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study
por: Marcum, Zachary A., et al.
Publicado: (2019)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019)

Estimates of diagnosed dementia prevalence and incidence among diverse beneficiaries in traditional Medicare and Medicare Advantage
por: Haye, Sidra, et al.
Publicado: (2023)

LGBTQIA+ Caregiving and Care Needs of Persons Living With Alzheimer’s Disease and Related Dementias
por: Flatt, Jason, et al.
Publicado: (2021)

Association of Angiotensin II–Stimulating Antihypertensive Use and Dementia Risk: Post Hoc Analysis of the PreDIVA Trial
por: van Dalen, Jan Willem, et al.
Publicado: (2021)

Sex and APOE genotype differences related to statin use in the aging population
por: Dagliati, Arianna, et al.
Publicado: (2021)

Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data
por: Lundin, Sori K., et al.
Publicado: (2023)

Antihypertensives in dementia: Good or bad for the brain?
por: Beishon, Lucy, et al.
Publicado: (2022)

Antihypertensives in dementia: Good or bad for the brain?
por: Heutz, Rachel AM, et al.
Publicado: (2023)

Evaluation of the Savvy Caregiver Program for LGBTQIA Adults Living With Alzheimer's Disease and Related Dementias
por: Flatt, Jason, et al.
Publicado: (2021)

Racial and ethnic differences in trends in dementia prevalence and risk factors in the United States
por: Chen, Cynthia, et al.
Publicado: (2018)

Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?
por: Chapman, Richard H, et al.
Publicado: (2009)

Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients
por: Torrandell-Haro, Georgina, et al.
Publicado: (2022)

Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer’s dementia?
por: Crum, Jana, et al.
Publicado: (2018)

“The impact of statins addind to the fixed combination antihypertensive therapy on the arterial stiffness in patients with moderate and severe hypertension"
por: Sirenko, Yuriy, et al.
Publicado: (2023)

Changes in physical and mental health of Black, Hispanic, and White caregivers and non‐caregivers associated with onset of spousal dementia
por: Chen, Cynthia, et al.
Publicado: (2020)

Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease
por: Chen, Shuhua, et al.
Publicado: (2011)

2-Deoxy-D-Glucose Treatment Induces Ketogenesis, Sustains Mitochondrial Function, and Reduces Pathology in Female Mouse Model of Alzheimer's Disease
por: Yao, Jia, et al.
Publicado: (2011)

Withdrawal of antihypertensive therapy in people with dementia: feasibility study
por: van der Wardt, Veronika, et al.
Publicado: (2018)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

Aortic Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage: Role of Antihypertensive Drugs and Statins
por: Varol, Ercan, et al.
Publicado: (2015)

Arterial stiffness evaluation in patients with irritable bowel syndrome: Role of antihypertensive drugs and statins
por: Varol, Ercan
Publicado: (2015)

Medicare's Annual Wellness Visit and diagnoses of dementias and cognitive impairment
por: Thunell, Johanna A., et al.
Publicado: (2022)

Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s Disease
por: Irwin, Ronald W., et al.
Publicado: (2012)

Response: Aortic Stiffness in Patients with Deep and Lobar Intracerebral Hemorrhage: Role of Antihypertensive Drugs and Statins
por: Acampa, Maurizio, et al.
Publicado: (2015)

Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data
por: Chen, Yi, et al.
Publicado: (2019)

Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
por: Irwin, Ronald W., et al.
Publicado: (2014)

Feasibility of the Savvy Caregiver Program for LGBTQ+ Caregivers of People Living with Alzheimer’s Disease and Related Dementias
por: Kittle, Krystal R., et al.
Publicado: (2022)

Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005)

The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?
por: Kehoe, Patrick Gavin
Publicado: (2018)

Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease
por: Zissimopoulos, Julie, et al.
Publicado: (2022)

Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer’s disease and dementia
por: Nerattini, Matilde, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t3d73jrh9uk4da87vfp9kfs64k